FI930603A0 - Aminosubstituerade bensoylguanidiner, foerfaranden foer deras framstaellning, anvaendning av dem som laekemedel samt laekemedel innehaollande desamma - Google Patents
Aminosubstituerade bensoylguanidiner, foerfaranden foer deras framstaellning, anvaendning av dem som laekemedel samt laekemedel innehaollande desammaInfo
- Publication number
- FI930603A0 FI930603A0 FI930603A FI930603A FI930603A0 FI 930603 A0 FI930603 A0 FI 930603A0 FI 930603 A FI930603 A FI 930603A FI 930603 A FI930603 A FI 930603A FI 930603 A0 FI930603 A0 FI 930603A0
- Authority
- FI
- Finland
- Prior art keywords
- ceiling
- benzoylguanidiner
- amenos
- anvaendning
- samt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4204577 | 1992-02-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI930603A0 true FI930603A0 (fi) | 1993-02-11 |
FI930603A FI930603A (fi) | 1993-08-16 |
Family
ID=6451809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI930603A FI930603A (fi) | 1992-02-15 | 1993-02-11 | Aminosubstituerade bensoylguanidiner, foerfaranden foer deras framstaellning, anvaendning av dem som laekemedel samt laekemedel innehaollande desamma |
Country Status (24)
Country | Link |
---|---|
US (1) | US5364868A (fi) |
EP (1) | EP0556672B1 (fi) |
JP (1) | JP3321473B2 (fi) |
KR (1) | KR100275603B1 (fi) |
AT (1) | ATE156485T1 (fi) |
AU (1) | AU658261B2 (fi) |
CA (1) | CA2089442C (fi) |
CZ (1) | CZ284456B6 (fi) |
DE (1) | DE59307039D1 (fi) |
DK (1) | DK0556672T3 (fi) |
ES (1) | ES2104971T3 (fi) |
FI (1) | FI930603A (fi) |
GR (1) | GR3024731T3 (fi) |
HU (1) | HU215851B (fi) |
IL (1) | IL104715A (fi) |
MA (1) | MA22798A1 (fi) |
MX (1) | MX9300784A (fi) |
NO (1) | NO302029B1 (fi) |
NZ (1) | NZ245896A (fi) |
PH (1) | PH30940A (fi) |
RO (1) | RO114131B1 (fi) |
RU (1) | RU2085555C1 (fi) |
TW (1) | TW224455B (fi) |
ZA (1) | ZA93986B (fi) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW250479B (fi) * | 1992-12-15 | 1995-07-01 | Hoechst Ag | |
DK0612723T3 (da) * | 1993-02-20 | 1998-03-30 | Hoechst Ag | Substituerede benzoylguanidiner, fremgangsmåde til fremstilling, deres anvendelse som lægemiddel, som inhibitor af den cellulære Na+/H+-udbytning eller som diagnostikum samt lægemiddel med indhold deraf |
US6190894B1 (en) | 1993-03-19 | 2001-02-20 | The Regents Of The University Of California | Method and compositions for disrupting the epithelial barrier function |
US6169107B1 (en) | 1993-04-28 | 2001-01-02 | Sumitomo Pharmaceutical Co., Ltd. | Indoloylguanidine derivatives |
IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4318658A1 (de) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4318756A1 (de) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4325822A1 (de) * | 1993-07-31 | 1995-02-02 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4337611A1 (de) * | 1993-11-04 | 1995-05-11 | Boehringer Ingelheim Kg | Neue Benzoylguanidine, ihre Herstellung und ihre Verwendung in Arzneimitteln |
TW415937B (en) * | 1994-01-25 | 2000-12-21 | Hoechst Ag | Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
DE4404183A1 (de) * | 1994-02-10 | 1995-08-17 | Merck Patent Gmbh | 4-Amino-1-piperidylbenzoylguanidine |
DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4415873A1 (de) * | 1994-05-05 | 1995-11-09 | Hoechst Ag | Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4421495A1 (de) * | 1994-06-20 | 1995-12-21 | Merck Patent Gmbh | Heterocyclyloxy-benzoylguanidine |
IL114670A0 (en) * | 1994-08-05 | 1995-11-27 | Fujisawa Pharmaceutical Co | Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4430213A1 (de) * | 1994-08-28 | 1996-02-29 | Merck Patent Gmbh | Arylbenzoylguanidine |
DE4430861A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
DE4430916A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Alkyl-benzoylguanidin-Derivate |
DE4432101A1 (de) * | 1994-09-09 | 1996-03-14 | Hoechst Ag | Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4441880A1 (de) * | 1994-11-24 | 1996-05-30 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
TW372967B (en) * | 1994-12-27 | 1999-11-01 | Kanebo Ltd | 1,4 benzoxazine derivative, pharmaceutical composition containing the same and use thereof |
DE19527305A1 (de) * | 1995-07-26 | 1997-01-30 | Hoechst Ag | Substituierte Zimtsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP0765868A1 (de) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarhythmika oder als Diagnostikum sowie sie enthaltendes Medikament |
EP0765867A1 (de) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament |
DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
JP3652708B2 (ja) * | 1997-03-06 | 2005-05-25 | トーアエイヨー株式会社 | シクロアルカ[b]ピリジン−3−カルボニルグアニジン誘導体、その製造法およびそれを含有する医薬品 |
DE19737463A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
DE19738604A1 (de) | 1997-09-04 | 1999-03-11 | Hoechst Marion Roussel De Gmbh | Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verminderung der Giftigkeit cardiotoxischer Stoffe |
DE19919349A1 (de) * | 1999-04-28 | 2000-11-02 | Merck Patent Gmbh | Verfahren zur Herstellung eines Benzoylguanidinderivates |
FR2842804B1 (fr) | 2002-07-29 | 2004-09-03 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
FR2861071B1 (fr) | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique |
FR2906251B1 (fr) | 2006-09-22 | 2008-11-07 | Sanofi Aventis Sa | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3006913A (en) * | 1959-06-10 | 1961-10-31 | Ciba Pharm Prod Inc | Process for preparing (n,n-alkylene-imino)-lower alkyl-guanidines |
US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
US3968243A (en) * | 1970-06-05 | 1976-07-06 | Burroughs Wellcome Co. | Substituted guanidine compounds in the treating of arrythmias |
DE2931735A1 (de) * | 1979-08-04 | 1981-02-19 | Beiersdorf Ag | Neue substituierte phenylacetylguanidine und verfahren zu ihrer herstellung |
EP0087218B1 (en) * | 1982-02-10 | 1985-05-02 | Beecham Group Plc | Guanidine derivatives |
US5190976A (en) * | 1986-07-10 | 1993-03-02 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And University Of Oregon | N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists |
DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
US5006523A (en) * | 1989-10-26 | 1991-04-09 | E. R. Squibb & Sons, Inc. | Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers |
DE59302959D1 (de) * | 1992-02-15 | 1996-07-25 | Hoechst Ag | 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen |
ATE158278T1 (de) * | 1992-02-15 | 1997-10-15 | Hoechst Ag | Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament |
DK0603650T3 (da) * | 1992-12-16 | 1997-10-20 | Hoechst Ag | 3,5-Substituerede aminobenzoylguanidiner, fremgangsmåde til deres freemstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf. |
-
1992
- 1992-12-31 CZ CS924033A patent/CZ284456B6/cs unknown
-
1993
- 1993-02-05 ES ES93101840T patent/ES2104971T3/es not_active Expired - Lifetime
- 1993-02-05 AT AT93101840T patent/ATE156485T1/de not_active IP Right Cessation
- 1993-02-05 DK DK93101840.2T patent/DK0556672T3/da active
- 1993-02-05 TW TW082100767A patent/TW224455B/zh active
- 1993-02-05 DE DE59307039T patent/DE59307039D1/de not_active Expired - Lifetime
- 1993-02-05 EP EP93101840A patent/EP0556672B1/de not_active Expired - Lifetime
- 1993-02-11 FI FI930603A patent/FI930603A/fi unknown
- 1993-02-11 RO RO93-00173A patent/RO114131B1/ro unknown
- 1993-02-11 US US08/016,535 patent/US5364868A/en not_active Expired - Lifetime
- 1993-02-12 CA CA002089442A patent/CA2089442C/en not_active Expired - Fee Related
- 1993-02-12 NO NO930512A patent/NO302029B1/no not_active IP Right Cessation
- 1993-02-12 PH PH45720A patent/PH30940A/en unknown
- 1993-02-12 AU AU33013/93A patent/AU658261B2/en not_active Ceased
- 1993-02-12 IL IL104715A patent/IL104715A/en not_active IP Right Cessation
- 1993-02-12 MX MX9300784A patent/MX9300784A/es unknown
- 1993-02-12 NZ NZ245896A patent/NZ245896A/en unknown
- 1993-02-12 MA MA23090A patent/MA22798A1/fr unknown
- 1993-02-12 HU HU9300368A patent/HU215851B/hu not_active IP Right Cessation
- 1993-02-12 JP JP02310993A patent/JP3321473B2/ja not_active Expired - Lifetime
- 1993-02-12 RU RU93004698/04A patent/RU2085555C1/ru not_active IP Right Cessation
- 1993-02-12 ZA ZA93986A patent/ZA93986B/xx unknown
- 1993-02-15 KR KR1019930002037A patent/KR100275603B1/ko not_active IP Right Cessation
-
1997
- 1997-09-16 GR GR970402375T patent/GR3024731T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI930603A (fi) | 1993-08-16 |
AU658261B2 (en) | 1995-04-06 |
NO930512L (no) | 1993-08-16 |
CA2089442A1 (en) | 1993-08-16 |
MX9300784A (es) | 1993-09-01 |
HU215851B (hu) | 2000-06-28 |
CA2089442C (en) | 2005-08-23 |
KR100275603B1 (ko) | 2000-12-15 |
IL104715A0 (en) | 1993-06-10 |
AU3301393A (en) | 1993-08-19 |
DE59307039D1 (de) | 1997-09-11 |
HUT63379A (en) | 1993-08-30 |
IL104715A (en) | 1998-02-08 |
EP0556672B1 (de) | 1997-08-06 |
MA22798A1 (fr) | 1993-10-01 |
DK0556672T3 (da) | 1998-03-02 |
US5364868A (en) | 1994-11-15 |
ES2104971T3 (es) | 1997-10-16 |
JP3321473B2 (ja) | 2002-09-03 |
ZA93986B (en) | 1993-09-20 |
NZ245896A (en) | 1995-04-27 |
CZ403392A3 (en) | 1993-12-15 |
NO302029B1 (no) | 1998-01-12 |
KR930017868A (ko) | 1993-09-20 |
RO114131B1 (ro) | 1999-01-29 |
NO930512D0 (no) | 1993-02-12 |
JPH0641049A (ja) | 1994-02-15 |
RU2085555C1 (ru) | 1997-07-27 |
HU9300368D0 (en) | 1993-04-28 |
PH30940A (en) | 1997-12-23 |
CZ284456B6 (cs) | 1998-12-16 |
GR3024731T3 (en) | 1997-12-31 |
TW224455B (fi) | 1994-06-01 |
EP0556672A1 (de) | 1993-08-25 |
ATE156485T1 (de) | 1997-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI930603A0 (fi) | Aminosubstituerade bensoylguanidiner, foerfaranden foer deras framstaellning, anvaendning av dem som laekemedel samt laekemedel innehaollande desamma | |
NO302469B1 (no) | Substituerte benzoylguanidiner, deres anvendelse for fremstilling av medikament eller diagnostikum såvel som legemidler inneholdende dem | |
RU93004698A (ru) | Аминозамещенные бензоилгуанидины, способ их получения и применение | |
IL105035A (en) | Substituted pipecolinic acid derivatives, their preparation and pharmaceutical compositions containing them | |
CA2158268A1 (en) | N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents | |
ES8301472A1 (es) | Procedimiento para la obtencion de derivados de imidazol trisustituidos | |
NO934604D0 (no) | Substituerte benzolguandiner, fremgangsmaater for fremstilling av disse, deres anvendelse som medikanementer eller diagnostikum saavel som medikamenter som inneholder dem | |
NO942062L (no) | Substituerte benzoylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
FI935617A0 (fi) | 3,5-substituerade aminobensoylguanidiner, foerfarande foer framstaellningav dem, anvaendning av dem som laekemedel eller diagnosticum samt laekemedel innehaollande desamma | |
NO942985L (no) | Ureasubstituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsene | |
TW429243B (en) | Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them | |
SE7508089L (sv) | N-sulfenylerade karbamater till anvendning som insekticider, akaricider och nematocider samt sett for deras framstellning. |